Vital Farms, Inc. Q2 2026 Earnings Recap

Vital Farms reported results in line with the recent challenges detailed last quarter, with the stock essentially unchanged post-earnings as investors weighed a 10.1% decline in net sales amid ongoing supply oversupply and price gap issues. Despite operational adjustments, margin compression and revenue decline kept the market response muted.

Key Takeaways

• Net sales declined 10.1% year-over-year, reflecting continued impact from industry-wide oversupply and branded competitor price gaps.
• Price gaps to branded competitors narrowed modestly from approximately $2.51 to $2.36, which contributed to improved velocity and household acquisition in targeted markets.
• Retail dollar share in the shell egg category grew by over 200 basis points year-over-year, signaling resilience within Vital Farms’ premium segment despite category-wide pricing pressure.
• Farmer contract amendments are now live, aimed at reducing excess supply and costly breaker sales; management reports oversupply likely peaked in Q2.
• Distribution points increased to approximately 148.7 year-to-date, with expectations to reach 170-175 TDPs by Q4 2026, supporting volume growth in H2.